Reier-Nilsen Tonje, Farstad Teresa, Nakstad Britt, Lauvrak Vigdis, Steinbakk Martin
Department of Pediatrics, Akershus University Hospital, Lørenskog, Norway.
BMC Pediatr. 2009 Jan 19;9:5. doi: 10.1186/1471-2431-9-5.
Early onset bacterial sepsis is a feared complication of the newborn. A large proportion of infants admitted to the Neonatal Intensive Care Unit (NICU) for suspected sepsis receive treatment with potent systemic antibiotics while a diagnostic workup is in progress. The gold standard for detecting bacterial sepsis is blood culture. However, as pathogens in blood cultures are only detected in approximately 25% of patients, the sensitivity of blood culture is suspected to be low. Therefore, the diagnosis of sepsis is often based on the development of clinical signs, in combination with laboratory tests such as a rise in C-reactive protein (CRP). Molecular assays for the detection of bacterial DNA in the blood represent possible new diagnostic tools for early identification of a bacterial cause.
A broad range 16S rDNA polymerase chain reaction (PCR) without preincubation was compared to conventional diagnostic work up for clinical sepsis, including BACTEC blood culture, for early determination of bacterial sepsis in the newborn. In addition, the relationship between known risk factors, clinical signs, and laboratory parameters considered in clinical sepsis in the newborn were explored.
Forty-eight infants with suspected sepsis were included in this study. Thirty-one patients were diagnosed with sepsis, only 6 of these had a positive blood culture. 16S rDNA PCR analysis of blinded blood samples from the 48 infants revealed 10 samples positive for the presence of bacterial DNA. PCR failed to be positive in 2 samples from blood culture positive infants, and was positive in 1 sample where a diagnosis of a non-septic condition was established. Compared to blood culture the diagnosis of bacterial proven sepsis by PCR revealed a 66.7% sensitivity, 87.5% specificity, 95.4% positive and 75% negative predictive value. PCR combined with blood culture revealed bacteria in 35.1% of the patients diagnosed with sepsis. Irritability and feeding difficulties were the clinical signs most often observed in sepsis. CRP increased in the presence of bacterial infection.
There is a need for PCR as a method to quickly point out the infants with sepsis. However, uncertainty about a bacterial cause of sepsis was not reduced by the PCR result, reflecting that methodological improvements are required in order for DNA detection to replace or supplement traditional blood culture in diagnosis of bacterial sepsis.
早发性细菌性败血症是新生儿令人担忧的并发症。很大一部分因疑似败血症入住新生儿重症监护病房(NICU)的婴儿在诊断检查进行期间接受强效全身抗生素治疗。检测细菌性败血症的金标准是血培养。然而,由于血培养中仅约25%的患者能检测到病原体,血培养的敏感性被怀疑较低。因此,败血症的诊断通常基于临床体征的出现,并结合实验室检查,如C反应蛋白(CRP)升高。检测血液中细菌DNA的分子检测方法是早期识别细菌病因的可能新诊断工具。
将无需预温育的广泛16S rDNA聚合酶链反应(PCR)与临床败血症的传统诊断检查(包括BACTEC血培养)进行比较,以早期确定新生儿细菌性败血症。此外,还探讨了新生儿临床败血症中已知危险因素、临床体征和实验室参数之间的关系。
本研究纳入了48例疑似败血症的婴儿。31例患者被诊断为败血症,其中只有6例血培养呈阳性。对48例婴儿的盲法血样进行16S rDNA PCR分析,发现10份样本存在细菌DNA呈阳性。血培养阳性婴儿的2份样本PCR未能呈阳性,而在确诊为非败血症疾病的1份样本中PCR呈阳性。与血培养相比,PCR诊断经证实的细菌性败血症的敏感性为66.7%,特异性为87.5%,阳性预测值为95.4%,阴性预测值为75%。PCR与血培养相结合,在35.1%被诊断为败血症的患者中检测到细菌。烦躁和喂养困难是败血症中最常观察到的临床体征。细菌感染时CRP升高。
需要将PCR作为一种快速指出败血症婴儿的方法。然而,PCR结果并未降低败血症细菌病因的不确定性,这反映出为使DNA检测在细菌性败血症诊断中取代或补充传统血培养,需要改进方法。